Hansen, Signe E. J.
Langsted, Anne
Varbo, Anette
Madsen, Christian M.
Tybjærg-Hansen, Anne
Nordestgaard, Børge G. http://orcid.org/0000-0002-1954-7220
Funding for this research was provided by:
novo nordisk fonden
det frie forskningsråd
overlæge johan boserup og lise boserups legat
herlev hospital
Article History
Received: 13 July 2021
Accepted: 20 August 2021
First Online: 5 September 2021
Declarations
:
: BGN reports consultancies or talks sponsored by AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. ATH reports consultancies for AstraZeneca, Silence Therapeutics, Novartis, Sanofi, Akcea, and Draupnir Bio. AV and CMM are currently employed at Novo Nordisk. SEJH and AL have no conflicts of interest.
: Coding will be made available upon reasonable request to corresponding author.
: The study was conducted in accordance with the Declaration of Helsinki and approved by local institutional reviews boards and Danish ethical committees (H-KF-01–144/01). <i>Consent to participate:</i> Written informed consent was obtained from all individuals.